Omaha, Nebraska, April 14, 2026 (GLOBE NEWSWIRE) -- Omaha, Nebraska - April 14, 2026 - - ...
At the 2026 ASCRS Annual Meeting in Washington, DC, several presentations converged on a set of questions that define the ...
Johnson & Johnson will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of Cataract and ...
ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.
Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S.
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and ...
Cataract surgery costs can add up, even with Medicare. Whitney Stidom of eHealth says Original Medicare Part B generally covers cataract removal and a traditional intraocular lens. After the ...
Preoperative corneal astigmatism is prevalent among cataract patients and has a negative effect on uncorrected distance visual acuity. Toric IOLs are commonly used to correct astigmatism and clinical ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results